4 completed, 3 unknown, 1 not yet recruiting, 1 recruiting. 3 Not applicable, 3 Phase 1, 1 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Not yet recruiting 1, Recruiting 1, Unknown 1 |
| Phase 1 | 3 | Unknown 2, Completed 1 |
| Phase 2 | 1 | Unknown 1 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Bone Morphogenetic Protein 2: new trials by email Literature Review of Bone Morphogenetic Protein 2 trials Research Report on Bone Morphogenetic Protein 2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Standard- and Micro-Dose rhBMP-2 for Implant Stability, Marginal Bone Loss, and Postoperative Sequelae: A Double-Blind Randomized Controlled Trial Standard-dose rhBMP-2, Micro-dose rhBMP-2, Sterile Normal Saline - Tooth Loss / Rehabilitation, Dental Implant | Not applicable | Not yet recruiting | University of Baghdad | 60 | 2026-12-01 | 2026-07-10 |
| Recombinant Human Bone Morphogenetic Protein-2(rhBMP-2) in Patients With Osteoporosis After Lumbar Fusion RhBMP-2 - Osteoporosis, Spinal Fusion | Not applicable | Unknown | Xijing Hospital | 76 | 2023-07-01 | 2023-06-22 |
| Comparison of Radiographic Fusion Rate and Clinical Outcome of ALIF and XLIF Performed With Either Recombinant Human Bone Morphogenetic Protein-2 or ViviGen® ViviGen®, rhBMP-2 - Spondylosis, Spondylolisthesis | Not applicable | Recruiting | Lindenhofgruppe AG | 168 | 2022-10-27 | 2026-08-26 |
| Effect of Recombinant Human Bone Morphogenetic Protein-2 With an Absorbable Collagen Sponge on Stability of Dental Implant: (Split Mouth Randomized Clinical Trial Study. rhBMP-2 - Hypertension, Diabetes Mellitus | Phase 1 | Unknown | University of Baghdad | 32 | 2021-12-06 | 2023-02-08 |
| Efficacy of Antiresorptive and Bone Forming Material on Dental Implants ALN Gel, BMP Gel, Mixed Gel - Partial Edentulism | Phase 1 / Phase 2 | Unknown | University of Baghdad | 20 | 2019-07-01 | 2019-10-25 |
| Lateral Ridge Augmentation Using Autogenous Bone Blocks or Xenogenic Bone Block Grafts Loaded With Recombinant Human Bone Morphogenic Protein 2 Autogenous bone graft, InductOs, Augmentation surgery - Missing Teeth | Phase 3 | Completed | University of Zurich | 24 | 2011-02-01 | 2021-12-02 |
| rhBMP-2 in Cervical Arthrodesis Cervical arthrodesis with rhBMP-2 - Cervical Arthrodesis | Completed | Virginia Spine Institute | 300 | 2008-10-01 | 2018-10-12 | |
| Parallel Study Between BMP-2 and Autologous Bone Graft After Ilizarow Treatment Bone Morphogenetic Protein 2, Autologous bone graft - Bone Degenerative Changes, Osteoarthritis | Phase 1 | Completed | Northern Orthopaedic Division, Denmark | 41 | 2004-09-01 | 2017-10-05 |
| Study Evaluating InductOs in Diaphyseal Tibia Fractures InductOs - Tibial Fractures | Phase 4 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 277 | 2003-09-01 | 2009-09-07 |
Ankylosis (1) · Anodontia (1) · Diabetes Mellitus (1) · Hematologic Diseases (1) · Hypertension (1) · Intervertebral Disc Degeneration (1) · Osteoarthritis (1) · Osteoporosis (1) · Spondylolisthesis (1) · Spondylosis (1) · Tibial Fractures (1) · Tooth Loss (1)
University of Baghdad (3) · Lindenhofgruppe AG (1) · Northern Orthopaedic Division, Denmark (1) · University of Zurich (1) · Virginia Spine Institute (1) · Wyeth is now a wholly owned subsidiary of Pfizer (1) · Xijing Hospital (1)
Iraq (3) · Switzerland (2) · Austria (1) · Belgium (1) · Denmark (1) · Finland (1) · France (1) · Germany (1) · Italy (1) · Netherlands (1) · Norway (1) · Poland (1) · Romania (1) · South Africa (1) · Spain (1)
Adbullah Al Abbas, B.D.S (1) · Brian R Subach, MD (1) · Daniel S Thoma, Prof. Dr. (1) · David Donnell, Advisor (1) · Diel Peter, Dr. med. (1) · Hans H. Hoeck, MD, Ph.D. (1) · Knud S. Christensen, MD (1) · Salwan Y Bede (1)